FDA truncates drug approval process; Makary pushes for more OTC drugs; Inside the rocky ride for Recursion Pharmaceuticals.

Danaher Corp. entered into a definitive agreement to acquire Masimo in an all-cash transaction valued at approximately $9.9 billion. Madrigal Pharmaceuticals signed an exclusive global license ...

Precision AQ, a 2025 MM+M Agency 100 honoree, appointed Emma Hawe as SVP, managing director of evidence synthesis and decision modelling as well as Yahya Anvar as SVP of data strategy and AI. Judi ...

NIH director to temporarily lead CDC; FDA switches up on Moderna vaccine; Trump officials tried to make peace with pharma; The mysterious symptom is popping up in some GLP-1 users.

Kimberly-Clark’s entire ad account has moved into McCann from FCB London, Omnicom confirmed. “The wider Kimberly-Clark business is moving into McCann. In this region, it will be managed out of McCann ...

Vicks took the top spot ahead of Rinvoq, Skyrizi and Tremfya, which continue to be the top spenders on national TV pharma ads.

It sounds like something from a science fiction novel, but Alabama officials’ plan to use robots to improve care for rural pregnant women and their babies is real.

The Congressional Budget Office told lawmakers in December 2024 that not extending the enhanced subsidies would cause 2.2 ...

Vaccine skeptics push to remove medical mandates at state level; The rollout of TrumpRx; Leadership chaos reigns at HHS, CDC.

The need for personalized, relevant engagement at the individual HCP level has never been greater — but to truly drive impact it must align with system priorities. In this session, Precision at Scale: ...

While no federal law overseeing AI in healthcare exists, regulators can rely on new state regulations as well as a deep well of existing laws to monitor the use of AI in healthcare and pharma ...